CYP2C19 testing

Operating since the beginning of the year in a pilot mode, the company officially launched its comprehensive PGx testing service last week.

A study led by researchers from Brigham and Women's Hospital on the effect of CYP2C19 testing on physicians' prescribing patterns has found that when doctors received patient test results for genetic markers associated with clopidogrel response through a pharmacy-benefit manager-

This article has been updated to clarify the information Spartan Bioscience plans to announce on upcoming studies.
By Molika Ashford

An ACCF/AHA panel has alerted doctors to evidence gaps regarding the clinical utility of genetic testing to administer Plavix, but not all cardiologists agree with the group's recommendations.

The boxed warning for Plavix's label alerts doctors that genetic tests are available to establish patients' CYP2C19 status. However, the FDA leaves it up to physicians to decide whether to wait for genetic testing results or put patients on an alternative treatment.

According to Quest, Scripps Health is "the first health system in the US to deploy this genetic testing service for coronary stent patients" receiving Plavix. The testing will initially be available for stent procedure patients presenting to Scripps Green Hospital in San Diego.

A genomic analysis of modern and ancient maize reveals a complicated domestication history, according to Reuters.

In PLOS this week: MYRF variant linked to congenital diaphragmatic hernia, analysis of the "dragon's blood" red resin produced by traditional medicine plants, and more.

CNBC reports that half of academic researchers leave after about five years.

Researchers have used genetic analysis to confirm a new type of salamander, the New York Times reports.